Nonprofits aren’t required to publicly disclose their donors. Some pharmaceutical companies voluntarily disclose at least some of their funding for patient groups, but the full scope of their giving is far from transparent.
A sign lines the drive up to rural doctor Emory Lewis' family practice on Dec. 12, 2011, in Reedville, Va., where he serves about 65 percent of patients insured by Medicare.
That’s not true for all of them, said Marc Boutin, the chief executive of the National Health Council, which has more than 50 patient groups and dozens of drugmakers as members. The charity’s headquarters, located behind an unmarked door in a building owned by Richard and Karen Moore, was locked on a recent weekday morning.
Kaiser Health News reported last year that 14 major drug companies gave a combined $116 million to patient groups in 2015, far more than the $63 million they spent on federal lobbying. In 2017, the group began running an informal coalition called the Protect Medicare Part D Working Group. It organized a January letter that called on Congress to reject plans for letting Medicare negotiate on drug prices; some 200 organizations signed it, including the U.S. Rural Health Network.
“We support lower prices, but we want to make sure that whatever is proposed actually makes the system better,” Gill said. Irene Bueno, a co-founder of NVG, said in an email that her firm is no longer involved in the effort; she didn’t answer questions about who funded her work. Lincoln Policy Group didn’t respond to several telephone calls and emails seeking comment.
Another patient group that popped up in 2017 shows how one pharmaceutical company tried to downplay its involvement.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump on opioid crisis: 'We are holding Big Pharma accountable'Trump pointed to drug-trafficking charges that federal prosecutors in New York filed against one of the largest drug distribution companies in the U.S.
Read more »
Why Big Pharma distrust is fueling the anti-vaxxer movement and playing a role in the measles outbreakAs distrust of the pharmaceutical industry grows, so too has the anti-vaccination movement. And that is a critical issue as measles cases balloon.
Read more »
Donald Trump doesn’t want big pharma’s money for his campaignPresident Donald Trump pledged to hold big pharma responsible for its role in fuelling America’s opioid crisis, which is killing 130 people a day.
Read more »
Kraft Heinz's CEO is the latest victim Big Food’s exodus of leadersKraft Heinz's CEO, Bernardo Hees, is the the latest CEO to announce his exit from a food company, as the industry goes through unprecedented turnover and challenges.
Read more »
The big mystery in the GDP report — where did the inventories come from?There is one big mystery in the first-quarter GDP report - where did all the inventories come from if industrial output and imports both were weak?
Read more »
Arya Stark's sexual awakening on 'Game of Thrones' is a big dealHolly Thomas writes that for young female audiences who are too often fed a diet of nerves and submission around first-time sex, Arya Stark's approach on 'Game of Thrones' marks a welcome shift toward sexual autonomy.
Read more »
Factbox: Big Democratic field taking shape for 2020 U.S. presidential raceThe largest Democratic field in the modern U.S. political era is lining up to se...
Read more »